Cargando…
Cell Division Cycle 6 Promotes Mitotic Slippage and Contributes to Drug Resistance in Paclitaxel-Treated Cancer Cells
Paclitaxel (PTX) is an antimitotic drug that possesses potent anticancer activity, but its therapeutic potential in the clinic has been hindered by drug resistance. Here, we report a mechanism by which cancer cells can exit from the PTX-induced mitotic arrest, i.e. mitotic slippage, and avoid subseq...
Autores principales: | He, Yue, Yan, Daoyu, Zheng, Dianpeng, Hu, Zhiming, Li, Hongwei, Li, Jinlong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5017606/ https://www.ncbi.nlm.nih.gov/pubmed/27611665 http://dx.doi.org/10.1371/journal.pone.0162633 |
Ejemplares similares
-
Caspase activity is not required for the mitotic checkpoint or mitotic slippage in human cells
por: Lee, Kyunghee, et al.
Publicado: (2011) -
Cdc6 contributes to cisplatin-resistance by activation of ATR-Chk1 pathway in bladder cancer cells
por: Chen, Sansan, et al.
Publicado: (2016) -
Low-dose paclitaxel synergizes with oncolytic adenoviruses via mitotic slippage and apoptosis in ovarian cancer
por: Ingemarsdotter, C K, et al.
Publicado: (2010) -
Pre-RC Protein MCM7 depletion promotes mitotic exit by Inhibiting CDK1 activity
por: Zheng, Dianpeng, et al.
Publicado: (2017) -
Different cell fates after mitotic slippage: From aneuploidy to polyploidy
por: Ohashi, Akihiro
Publicado: (2015)